SIGN UP
LOG IN
News
BAYRY
7.04
-0.14%
-0.01
MOO ETF: Agriculture Stocks Are Inexpensive and Defensive
TipRanks · 23h ago
Bayer dethroned as Germany’s top drugmaker
Privately owned Boehringer Ingelheim surpassed German pharma giant Bayer as the country’s largest drugmaker. Bayer reported €20.8B in pharmaceutical sales in 2023. Sales from China fell below expectations as sales of Xarelto with J&J dropped below expectations.
Seeking Alpha · 2d ago
Bayer's Consumer-Healthcare Unit Remains Attractive Acquisition Target -- Market Talk
Barclays says Bayer's consumer-healthcare unit could be a good acquisition target. The German company last month ruled out changes to its structure for now. Reckitt Benckiser, Procter & Gamble and Nestle seem to have the least overlap with Bayer's portfolio.
Dow Jones · 3d ago
Weekly Report: what happened at BAYRY last week (0408-0412)?
Weekly Report · 3d ago
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
NASDAQ · 6d ago
Ginkgo Bioworks acquires AgBiome's platform assets
Cell platform company Ginkgo Bioworks acquires AgBiome's platform assets. Financial terms of the transaction were not disclosed. The company bought Bayer's agricultural biologicals R&D facility in 2022. Gink go bioworks will buy Ag biome's biological assets.
Seeking Alpha · 04/11 11:45
Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Joshua Brown says Nasdaq, Inc. Is going higher. Spotify Technology S.A. Is expected to report first-quarter earnings on April 23. The Charles Schwab Corporation is the way to play gold and copper.
Benzinga · 04/10 13:13
Oakmark International Fund: First Calendar Quarter 2024 Commentary
The Oakmark International Fund returned 0.11% for the quarter ended March 31, compared to the benchmark, the MSCI World ex USA Index. Daimler Truck Holding was a top contributor during the quarter. Bayer is a top detractor during the same period.
Seeking Alpha · 04/10 08:00
Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
Bayer AG and Google Cloud announced a collaboration to develop artificial intelligence (AI) solutions to support radiologists. Bayer will develop a platform to accelerate the development of AI-powered healthcare applications. The platform will use Google Cloud’s generative AI tools to flag anomalies in medical images and pull up relevant information.
Benzinga · 04/09 18:13
Google, Bayer in pact for AI-powered radiology tools
Seeking Alpha · 04/09 14:27
Weekly Report: what happened at BAYRY last week (0401-0405)?
Weekly Report · 04/08 11:48
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst
Needham analyst says Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma. The three companies are the most likely to be acquired in Needham's coverage universe. Needham expects M&A activity to remain above average for the remainder of 2024.
Seeking Alpha · 04/07 12:00
Bayer Roundup cancer jury award cut by nearly two-thirds to $550M
Bayer Roundup cancer jury award cut by nearly two-thirds to $550M. Three former users of the company's weedkiller blamed their cancers on the product. Jury awarded the three plaintiffs a total of $1.5B in November. Bayer has lost 70% of its market value since its acquisition of Monsanto.
Seeking Alpha · 04/05 20:43
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
Investors are turning their attention to the realm of corporate bonds. Inflows into corporate bond funds have surged to $22.8 billion in 2024. Corporate bonds come in two main types: investment-grade and high-yield. Benzinga lists the top 10 investment- grade corporate bonds with the highest yields as of April 2024.
Benzinga · 04/05 16:24
Weekly Report: what happened at BAYRY last week (0325-0329)?
Weekly Report · 04/01 11:44
2 More Potential Biotech Buyout Targets
Oncology is projected to reach $375 billion in sales by 2027. The oncology space continues to be a hot and active area for M&A activity. Exelixis is one of two smaller companies that appear to be logical buyout targets for larger companies. The company is a mid-cap oncologist with a strong pipeline.
Seeking Alpha · 03/25 17:07
Weekly Report: what happened at BAYRY last week (0318-0322)?
Weekly Report · 03/25 11:48
One CEO's Radical Fix for Corporate Troubles: Purge the Bosses
Bayer CEO Bill Anderson is trying to cut costs by 2 billion euros. The German company's stock is down 50% from a year ago. Anderson's idea: Employees will be recruited to teams that decide on projects and work together for 90 days. He says the company will operate 5,000 to 6,000 self-directed teams.
The Wall Street Journal · 03/22 04:01
New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding -- Journal Report
New class of anticoagulant drugs could help prevent blood clots that cause heart attacks and strokes. At least a half-dozen experimental blood thinners are in development that inhibit a protein called factor XI. Researchers believe factor XI plays a minimal role in forming the good clots to stop bleeding. Many patients refuse to take the drugs because of the high risk of bleeding.
The Wall Street Journal · 03/21 19:00
New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding -- Journal Report -2-
Low bleeding risk could also make factor XI inhibitors candidates to help prevent recurrent events in patients who have already suffered a stroke. Bristol-Myers and J&J could see the results of their studies in these indications in 2026. Standard of care for such patients are anticoagulants that increase bleeding risk.
The Wall Street Journal · 03/21 19:00
More
Webull provides a variety of real-time BAYRY stock news. You can receive the latest news about Bayer Aktien through multiple platforms. This information may help you make smarter investment decisions.
About BAYRY
Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non